argenx SE reported $426M in Pre-Tax Profit for its fiscal quarter ending in March of 2026.





Pre Tax Profit Change Date
AstraZeneca USD 4.81B 894M Jun/2026
Genmab DKK 55M 427M Dec/2025
GlaxoSmithKline GBP 2.68B 532M Jun/2026
GRIFOLS EUR 247M 135M Jun/2026
Hikma Pharmaceutical USD 147.5M 3.5M Jun/2025
Lakefront Biotherapeutics EUR 13.96M 769.2M Mar/2026
Qiagen NV USD 85.83M 23.34M Mar/2026
UCB EUR 789M 427M Jun/2025